These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3828996)

  • 41. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells.
    Krahenbuhl JL; Remington JS
    Cancer Res; 1977 Nov; 37(11):3912-6. PubMed ID: 908031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M; Haskill S
    J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB; Serrou B
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G; Gittel H; Ben-Efraim S
    Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    J Immunol; 1985 Jul; 135(1):679-83. PubMed ID: 3839006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The resistance of in vivo selected tumor cells of malignant phenotype to the cytolytic action of activated peritoneal macrophages in vitro].
    Vol'pe EA
    Biull Eksp Biol Med; 1991 Feb; 111(2):177-9. PubMed ID: 1854964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice.
    Stoychkov JN; Schultz RM; Chirigos MA; Pavlidis NA; Goldin A
    Cancer Res; 1979 Aug; 39(8):3014-7. PubMed ID: 455286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of activated macrophages on tumor target cells in discrete phases of the cell cycle.
    Krahenbuhl JL
    Cancer Res; 1980 Dec; 40(12):4622-7. PubMed ID: 7438096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Killing of tumor cells in vitro by macrophages from mice given injections of squalene-treated cell wall skeleton of Nocardia rubra.
    Ito M; Iizuka H; Masuno T; Yasunami R; Ogura T; Yamamura Y; Azuma I
    Cancer Res; 1981 Jul; 41(7):2925-30. PubMed ID: 7248952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Killing of tumor cells in vitro by macrophages from mice treated with synthetic dehydrodipeptides.
    Schorlemmer HU; Opitz W; Etschenberg E; Bitter-Suermann D; Hadding U
    Cancer Res; 1979 May; 39(5):1847-53. PubMed ID: 427817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inducible macrophage cytotoxins. II. Tumor lysis mechanism involving target cell-binding proteases.
    Reidarson TH; Granger GA; Klostergaard J
    J Natl Cancer Inst; 1982 Oct; 69(4):889-94. PubMed ID: 6750198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E; Ulich T; Schreiber RD
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
    Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
    J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.